Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY
Wall Street called the missed CVS Caremark formulary date a "negative shock" — a securities class action alleges ARS Pharmaceuticals built analyst expectations on a July 1, 2026 coverage timeline that was never disclosed as at risk of slipping to January 2027. NEW YORK, Sept. 30, 2026...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is up 0.2% since this was published, 22 days ago.
- CVS Health is up 10.3% since this was published, 22 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.